S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
NYSEARCA:BTAL

AGFIQ US MARKET NEUTRAL ANTI-BETA FUND Stock Forecast, Price & News

$16.94
-0.18 (-1.05%)
(As of 12/8/2021 12:00 AM ET)
Add
Today's Range
$16.88
$17.10
50-Day Range
$16.20
$17.51
52-Week Range
$16.15
$19.58
Volume
18,255 shs
Average Volume
65,154 shs
Market Capitalization
$99.95 million
P/E Ratio
N/A
Dividend Yield
0.00%
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive BTAL News and Ratings via Email

Sign-up to receive the latest news and ratings for AGFIQ US MARKET NEUTRAL ANTI-BETA FUND and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer AGFiQ
Fund NameAGFIQ US MARKET NEUTRAL ANTI-BETA FUND
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:BTAL
Inception Date9/12/2011
Fund ManagerWilliam DeRoche, Philip Lee
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkDow Jones U.S. Thematic Market Neutral Anti-Beta Total Return Index
CategoryStrategy
FocusLong/Short
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$100.62 million
Average Daily Volume$50.51 thousand
Discount/Premium0.07%

ETF Expenses

Management Fee0.45%
Other Expenses2.56%
Total Expenses3.01%
Fee Waiver-0.48%
Net Expenses2.53%

Administrator, Advisor and Custodian

AdministratorJ.P. Morgan Investor Services Co.
AdvisorFFCM LLC
CustodianJPMorgan Chase Bank, N.A.
DistributorForeside Fund Services, LLC
Transfer AgentJPMorgan Chase Bank, N.A.
Trustee
Lead Market Maker

Geographic Exposure of BTAL

Currency Exposure of BTAL

Sector Exposure of BTAL

Industry Exposure of BTAL













AGFIQ US MARKET NEUTRAL ANTI-BETA FUND (NYSEARCA:BTAL) Frequently Asked Questions

How has AGFIQ US MARKET NEUTRAL ANTI-BETA FUND's stock been impacted by Coronavirus?

AGFIQ US MARKET NEUTRAL ANTI-BETA FUND's stock was trading at $26.07 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, BTAL stock has decreased by 35.0% and is now trading at $16.94.
View which stocks have been most impacted by COVID-19
.

What other stocks do shareholders of AGFIQ US MARKET NEUTRAL ANTI-BETA FUND own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AGFIQ US MARKET NEUTRAL ANTI-BETA FUND investors own include Ajinomoto (AJINY), Advanced Energy Industries (AEIS), Autodesk (ADSK), Koninklijke Ahold Delhaize (ADRNY), Accenture (ACN), American Campus Communities (ACC), Abbott Laboratories (ABT), AbbVie (ABBV), Axon Enterprise (AAXN) and AAON (AAON).

What is AGFIQ US MARKET NEUTRAL ANTI-BETA FUND's stock symbol?

AGFIQ US MARKET NEUTRAL ANTI-BETA FUND trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "BTAL."

Who are AGFIQ US MARKET NEUTRAL ANTI-BETA FUND's major shareholders?

AGFIQ US MARKET NEUTRAL ANTI-BETA FUND's stock is owned by a number of retail and institutional investors. Top institutional investors include IFP Advisors Inc (0.42%) and AGF Investments LLC (0.07%).

Which major investors are buying AGFIQ US MARKET NEUTRAL ANTI-BETA FUND stock?

BTAL stock was purchased by a variety of institutional investors in the last quarter, including IFP Advisors Inc, and AGF Investments LLC.

How do I buy shares of AGFIQ US MARKET NEUTRAL ANTI-BETA FUND?

Shares of BTAL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AGFIQ US MARKET NEUTRAL ANTI-BETA FUND's stock price today?

One share of BTAL stock can currently be purchased for approximately $16.94.

How much money does AGFIQ US MARKET NEUTRAL ANTI-BETA FUND make?

AGFIQ US MARKET NEUTRAL ANTI-BETA FUND has a market capitalization of $99.95 million.


This page was last updated on 12/9/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.